The Sunday Guardian

Domestic virus test kits await ICMR nod for mass use

- KUNDAN JHA NEW DELHI

It is expected that ICMR will ensure that India becomes a global hub for making low-cost test kits.

The prestigiou­s Indian Council of Medical Research (ICMR) needs to ensure the removal of existing delays in the manufactur­ing of homegrown Wuhan virus testing kits, sources dealing with testing kits say.

Feedback from the country’s domestic pharma sector has caused the ICMR to be active and change its validation norms. Initially, many companies waited for several months to get the validation process done. The ICMR has now added four more validation centers besides the ICMRNIV (National Institute of

Virology) Pune, but industry sources say many more are needed.

“Knowing the harshness of the situation and the need for having a large number of Wuhan virus testing kits in the country, officials at the ICMR needed to take timely action to ensure fast production of indigenous­ly manufactur­ed Wuhan virus testing kits. This has left the field to companies selling imported test kits and they were not in a position to locally manufactur­e the test kits,” a source close to the ICMR told The Sunday Guardian. It is expected that ICMR will ensure that India becomes a global hub for the manufactur­e of low-cost test kits and medicines rather than remain dependent on imported drugs and kits.

The same source cited above said: “It is worth noticing that the previous norms for manufactur­ing home-grown testing kits were restrictiv­e in nature, at least for domestic Indian companies, as according to the old provisions, having USFDA (U.S. Food and Drug Administra­tion) and European CE (Conformitè Europëenne) was mandatory for the manufactur­ing of the kits.”

“Cosara—a joint venture of Co-diagnostic­s Inc of Utah, USA, and Ambalal Sarabhai Enterprise­s of India—was not in a position to begin commercial manufactur­e of the Wuhan virus testing kits anywhere despite becoming first to get the CDSCO (Central Drugs Standard Control Organisati­on) licence. In contrary, the lone Indian company, Mylab Discovery Solutions, which got the validation process done only a week ago after the new norms came into place, have already supplied the indigenous­ly manufactur­ed kits and this was possible because of having locally procured raw material,” the same source cited above said.

Mylab’s Wuhan virus testing kits will not only limit the country’s dependency on the imported kits from the US,

Newspapers in English

Newspapers from India